Journal
CHEMISTRY-A EUROPEAN JOURNAL
Volume 26, Issue 68, Pages 15953-15968Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.202002401
Keywords
bacteria; biochemistry; glycosylation; salmonella paratyphi A; synthesis; vaccine
Categories
Funding
- National Institute of Allergy and Infectious Diseases, NIH [R01AI146210]
- Michigan State University
- Council of Scientific and Industrial Research (CSIR), India [02(0237)/15/ EMR-II]
Ask authors/readers for more resources
With the emergence of multidrug resistantSalmonellastrains, the development of anti-Salmonellavaccines is an important task. Currently there are no approved vaccines againstSalmonellaParatyphi A, the leading cause of paratyphoid fever. To fill this gap, oligosaccharides corresponding to theO-polysaccharide repeating units from the surface ofSalmonellaParatyphi A have been synthesized through convergent stereoselective glycosylations. The synthetic glycan antigen was conjugated with a powerful immunogenic carrier system, the bacteriophage Q beta. The resulting construct was able to elicit strong and long-lasting anti-glycan IgG antibody responses, which were highly selective towardSalmonellaParatyphi A associated glycans. The availability of well-defined glycan antigen enabled the determination that one repeating unit of the polysaccharide is sufficient to induce protective antibodies, and the paratose residue and/or theO-acetyl modifications on the backbone are important for recognition by antibodies elicited by a Q beta-tetrasaccharide conjugate. Immune sera provided excellent protection to mice from lethal challenge withSalmonellaParatyphi A, highlighting the potential of the synthetic glycan-based vaccine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available